Related Experiment Video

Updated: Aug 7, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?

Ester Fonsatti1, Anna Maria Di Giacomo, Michele Maio

  • 1Cancer Bioimmunotherapy Unit, Department of Medical Oncology, Centro di Riferimento Oncologico, I,R,C,C,S, 33081 Aviano, Italy. mmaio@cro.it

Journal of Translational Medicine
|June 29, 2004
PubMed

Insights

Monoclonal antibodies (mAbs) offer promising cancer immunotherapy, but efficacy is limited. Targeting membrane complement-regulatory proteins like Protectin (CD59) could enhance mAb effectiveness in cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biochemistry

Background:

  • Monoclonal antibodies (mAbs) are a rapidly growing area of cancer biological therapy.
  • Limited clinical efficacy of therapeutic mAbs has been observed in selected neoplasias.
  • Optimizing mAb therapy requires deeper characterization of neoplastic cell biological features.

Discussion:

  • Focusing on membrane complement-regulatory proteins, such as Protectin (CD59), is crucial.
  • Protectin (CD59) normally protects tissues from complement-mediated damage.
  • Understanding its role can refine antibody-based immunotherapy strategies.

Key Insights:

  • Identifying specific biological features of cancer cells is key to improving mAb therapy.
  • Therapeutic potential of mAbs can be optimized by understanding these features.
  • Identifying ideal candidates for antibody-based immunotherapy is essential.

Outlook:

  • Investigating the tissue distribution and function of Protectin (CD59) can enhance efficacy.
  • Complement (C)-activating mAb strategies may be optimized by targeting these proteins.
  • This approach could lead to more effective cancer treatment options.

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...